1091 related articles for article (PubMed ID: 25855666)
1. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
[TBL] [Abstract][Full Text] [Related]
2. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
[TBL] [Abstract][Full Text] [Related]
3. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease.
Idilman IS; Keskin O; Elhan AH; Idilman R; Karcaaltincaba M
Scand J Gastroenterol; 2014 May; 49(5):617-24. PubMed ID: 24694249
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.
Achmad E; Yokoo T; Hamilton G; Heba ER; Hooker JC; Changchien C; Schroeder M; Wolfson T; Gamst A; Schwimmer JB; Lavine JE; Sirlin CB; Middleton MS
Abdom Imaging; 2015 Oct; 40(8):3084-90. PubMed ID: 26205992
[TBL] [Abstract][Full Text] [Related]
5. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents.
Di Martino M; Pacifico L; Bezzi M; Di Miscio R; Sacconi B; Chiesa C; Catalano C
World J Gastroenterol; 2016 Oct; 22(39):8812-8819. PubMed ID: 27818597
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
[TBL] [Abstract][Full Text] [Related]
7. Quantification of liver, pancreas, kidney, and vertebral body MRI-PDFF in non-alcoholic fatty liver disease.
Idilman IS; Tuzun A; Savas B; Elhan AH; Celik A; Idilman R; Karcaaltincaba M
Abdom Imaging; 2015 Aug; 40(6):1512-9. PubMed ID: 25715922
[TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
[TBL] [Abstract][Full Text] [Related]
9. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Satkunasingham J; Nik HH; Fischer S; Menezes R; Selzner N; Cattral M; Grant D; Jhaveri K
Liver Transpl; 2018 Apr; 24(4):470-477. PubMed ID: 29080242
[TBL] [Abstract][Full Text] [Related]
10. Intra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults.
Tyagi A; Yeganeh O; Levin Y; Hooker JC; Hamilton GC; Wolfson T; Gamst A; Zand AK; Heba E; Loomba R; Schwimmer J; Middleton MS; Sirlin CB
Abdom Imaging; 2015 Oct; 40(8):3070-7. PubMed ID: 26350282
[TBL] [Abstract][Full Text] [Related]
11. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.
Noureddin M; Lam J; Peterson MR; Middleton M; Hamilton G; Le TA; Bettencourt R; Changchien C; Brenner DA; Sirlin C; Loomba R
Hepatology; 2013 Dec; 58(6):1930-40. PubMed ID: 23696515
[TBL] [Abstract][Full Text] [Related]
12. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.
Permutt Z; Le TA; Peterson MR; Seki E; Brenner DA; Sirlin C; Loomba R
Aliment Pharmacol Ther; 2012 Jul; 36(1):22-9. PubMed ID: 22554256
[TBL] [Abstract][Full Text] [Related]
13. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes.
Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A
J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609
[TBL] [Abstract][Full Text] [Related]
14. The Accuracy and Clinical Relevance of the Multi-echo Dixon Technique for Evaluating Changes to Hepatic Steatosis in Patients with Non-alcoholic Fatty Liver Disease Treated with Formulated Food.
Yang Y; Xu K; Chen X; Ding J; Shi J; Li J
Magn Reson Med Sci; 2023 Apr; 22(2):263-271. PubMed ID: 35676065
[TBL] [Abstract][Full Text] [Related]
15. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range.
Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G
J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848
[TBL] [Abstract][Full Text] [Related]
16. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantification of hepatic MRI-PDFF and R2* in a rabbit model with nonalcoholic fatty liver disease.
Wang X; Zhang X; Ma L; Li S
Sci China Life Sci; 2018 Sep; 61(9):1107-1114. PubMed ID: 29934919
[TBL] [Abstract][Full Text] [Related]
18. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
[TBL] [Abstract][Full Text] [Related]
19. Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects.
Artz NS; Haufe WM; Hooker CA; Hamilton G; Wolfson T; Campos GM; Gamst AC; Schwimmer JB; Sirlin CB; Reeder SB
J Magn Reson Imaging; 2015 Sep; 42(3):811-7. PubMed ID: 25620624
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.
Zand KA; Shah A; Heba E; Wolfson T; Hamilton G; Lam J; Chen J; Hooker JC; Gamst AC; Middleton MS; Schwimmer JB; Sirlin CB
J Magn Reson Imaging; 2015 Nov; 42(5):1223-32. PubMed ID: 25847512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
